175 related articles for article (PubMed ID: 18574113)
1. Comparison of cryotherapy to imiquimod 5% in the treatment of anogenital warts.
Stefanaki C; Katzouranis I; Lagogianni E; Hadjivassiliou M; Nicolaidou E; Panagiotopoulos A; Anyfantakis V; Bethimoutis G; Rallis E; Antoniou C; Katsambas A
Int J STD AIDS; 2008 Jul; 19(7):441-4. PubMed ID: 18574113
[TBL] [Abstract][Full Text] [Related]
2. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
[TBL] [Abstract][Full Text] [Related]
4. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
Lafuma A; Monsonego J; Moyal-Barracco M; Pribil C
Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
6. Effect of imiquimod in anogenital warts from HIV-positive men.
Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for the response to treatment in males with genital warts.
Stefanaki C; Hadjivassiliou M; Katzouranis I; Bethimoutis G; Nicolaidou E; Anyfantakis V; Lagogianni E; Caroni C; Panagiotopoulos A; Antoniou C; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1156-60. PubMed ID: 19453776
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
9. Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study.
Arican O; Guneri F; Bilgic K; Karaoglu A
J Dermatol; 2004 Aug; 31(8):627-31. PubMed ID: 15492435
[TBL] [Abstract][Full Text] [Related]
10. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
[TBL] [Abstract][Full Text] [Related]
11. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
Diamantis ML; Bartlett BL; Tyring SK
Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
[TBL] [Abstract][Full Text] [Related]
12. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
Cox JT
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():51-4. PubMed ID: 14616817
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.
Bonnez W; Elswick RK; Bailey-Farchione A; Hallahan D; Bell R; Isenberg R; Stoler MH; Reichman RC
Am J Med; 1994 May; 96(5):420-5. PubMed ID: 8192173
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Vexiau D; Decuypère L; Moyse D; Aractingi S
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod in clinical practice.
Edwards L
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
[TBL] [Abstract][Full Text] [Related]
16. Update on the treatment of genital warts.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18559. PubMed ID: 24011309
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
18. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
Carrasco D; vander Straten M; Tyring SK
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
[TBL] [Abstract][Full Text] [Related]
20. [Anogenital warts: a new way of solving the common problem of urology (results of long-term follow-up)].
Protasov AD; Lipatov IS; Kostinov MP; Tezikov YV; Shmitko AD; Pakhomov DV; Blagovidov DA; Zhestkov AV; Ryzhov AA; Vekhova EV
Urologiia; 2016 Nov; (5):47-51. PubMed ID: 28248020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
